Today the FDA published a notice announcing public hearings on November 2 and 3, 2010 on implementation of the Biologics Price Competition and Innovation Act of 2009 (BPCI Act), which was enacted as part of the Affordable Care Act (ACA).┬áThe BPCI Act establishes an abbreviated approval pathway for biological products that are demonstrated to be … Continue Reading